Clinical Trials Directory

Trials / Unknown

UnknownNCT04224649

To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

A Single Center, Randomized, Subject & Evaluator-blind, Matched Pairs, Active-controlled Design Pivotal Study to Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
67 (estimated)
Sponsor
Huons Co., Ltd. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

* Investigational Device : HARA (Hyaluronic Acid Filler) * Title : A Single center, Randomized, Subject \& Evaluator-blind, Matched pairs, Active-controlled design Pivotal study to Evaluate the Efficacy and Safety of Injection with HARA as Compared to Restylane® Lidocaine in temporary Correction of Nasolabial folds * Sites and investigators : Chung-ang University Hospital(Seoul), Beom-Joon Kim, M.D, Ph.D * Objective : To compare the non-inferiority of HARA with Restylane® Lidocaine for evaluation of the efficacy and safety on Nasolabial Folds

Conditions

Interventions

TypeNameDescription
DEVICEHARA Filler(Hyaluronic acid Filler)The same participants received the experimental device and the active comparator device at the same time (left and right sides of face).
DEVICERestylane® LidocaineThe same participants received the experimental device and the active comparator device at the same time (left and right sides of face).

Timeline

Start date
2019-04-23
Primary completion
2020-01-30
Completion
2020-07-30
First posted
2020-01-13
Last updated
2020-01-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04224649. Inclusion in this directory is not an endorsement.